pubrio
Global Health Innovative Technology (GHIT) Fund

Global Health Innovative Technology (GHIT) Fund

Japan · Non-profit Organizations

Nonprofit Organization Management

Research

Pharmaceuticals

Healthcare

Non-profit Organizations

The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, and international philanthropic foundations.

Company Insights
Company Overview

2013

Founded

Non-profit Organizations

Industry

Japan

Location

1,378,600

Ranking

22 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Global Health Innovative Technology (GHIT) Fund

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​